COPD and asthma: the main noncommunicable diseases that should be tackled?

A. Spanevello (Milan, Italy)

Source: International Congress 2018 – New challenges in tackling known diseases with the 10 ERS Principles for Lung Health
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Spanevello (Milan, Italy). COPD and asthma: the main noncommunicable diseases that should be tackled?. International Congress 2018 – New challenges in tackling known diseases with the 10 ERS Principles for Lung Health

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology of non-communicable diseases: asthma and COPD
Source: Online Course 2014 - Respiratory epidemiology
Year: 2014


The economic burden of respiratory diseases: COPD and asthma
Source: Eur Respir Monogr 2014; 65: 116-124
Year: 2014


Chronic diseases like asthma and COPD: do they truly exist?
Source: Eur Respir J 2016; 47: 359-361
Year: 2016


Tuberculosis and noncommunicable diseases: neglected links and missed opportunities
Source: Eur Respir J 2011; 37: 1269-1282
Year: 2011



Prioritised research agenda for prevention and control of chronic respiratory diseases
Source: Eur Respir J 2010; 36: 995-1001
Year: 2010



A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma
Source: Eur Respir J 2003; 22: 397-398
Year: 2003


The best papers in the ERJ: chronic airways diseases, including asthma and COPD
Source: Virtual Congress 2020 – The European Respiratory Journal editor's view: our best papers of last year
Year: 2020


GBD 2017 estimates on asthma, COPD and other: challenges to measure respiratory disease worldwide
Source: International Congress 2019 – The Global Burden of Disease, Global Alliance for Chronic Diseases and Forum of International Respiratory Societies and other international initiatives
Year: 2019


Mobile cardio-respiratory metabolic laboratory as effective tool in early diagnosis of COPD and other chronic non-communicable diseases (CNCDs) in organized busy groups of employees
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015

COPD: an autoimmune disease?
Source: Eur Respir J 2011; 38: 484
Year: 2011


Comorbidities – should we and how should we treat them in asthma and COPD?
Source: International Congress 2014 – PG02 Current clinical problems in pulmonology
Year: 2014




Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality?
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


Epidemiology of COPD: social burden and trends for the future
Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management
Year: 2006



An invisible disease: severe asthma is more than just “bad asthma”
Source: Eur Respir J, 50 (3) 1701109; 10.1183/13993003.01109-2017
Year: 2017



Household pollution and obstructive diseases: asthma and COPD
Source: Virtual Congress 2020 – Spanish/Portuguese programme 2020: Part II
Year: 2020


Underrepresentation of patients with cardiovascular diseases in trials of chronic obstructive pulmonary disease: Transferability problems in general practice?
Source: Annual Congress 2010 - Management of airway disease
Year: 2010